Adverse reactions and influencing factors in children with primary immunodeficiencies receiving intravenous immunglobulin replacement.

[1]  A. Aghamohammadi,et al.  The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases. , 2016, Endocrine, metabolic & immune disorders drug targets.

[2]  N. Rezaei,et al.  Managing patients with side effects and adverse events to immunoglobulin therapy , 2016, Expert review of clinical pharmacology.

[3]  J. Zimring.  Do immune complexes play a role in hemolytic sequelae of intravenous immune globulin? , 2015, Transfusion.

[4]  D. Leitch,et al.  The health implications of low hemoglobin deferral in infrequent blood donors , 2015, Transfusion.

[5]  B. Costa-Carvalho,et al.  Immediate infusion-related adverse reactions to intravenous immunoglobulin in a prospective cohort of 1765 infusions. , 2014, International immunopharmacology.

[6]  S. L. Kwong,et al.  Adverse events of intravenous immunoglobulin infusions: a ten-year retrospective study , 2013, Asia Pacific allergy.

[7]  E. R. Stiehm,et al.  Adverse effects of human immunoglobulin therapy. , 2013, Transfusion medicine reviews.

[8]  H. Schroeder,et al.  Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients , 2012, Infection.

[9]  J. Church,et al.  Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency , 2012, Journal of Clinical Immunology.

[10]  H. Hartung,et al.  Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy. , 2010, Archives of neurology.

[11]  D. Singh-Grewal,et al.  A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions , 2006, Archives of Disease in Childhood.

[12]  W. Struff,et al.  Safety monitoring of a polyvalent immunoglobulin preparation: documentation of 15,548 administrations. , 2005, International journal of clinical pharmacology and therapeutics.

[13]  F. Bonilla.  PROSPECTIVE AUDIT OF ADVERSE REACTIONS OCCURRING IN 459 PRIMARY ANTIBODY-DEFICIENT PATIENTS RECEIVING INTRAVENOUS IMMUNOGLOBULIN , 2004, Pediatrics.

[14]  J. Sinclair,et al.  Increased risk of adverse events when changing intravenous immunoglobulin preparations , 2004, Clinical and experimental immunology.

[15]  H. Chapel,et al.  Prospective audit of adverse reactions occurring in 459 primary antibody‐deficient patients receiving intravenous immunoglobulin , 2003, Clinical and experimental immunology.

[16]  H. Simon,et al.  IVIG – mechanisms of action , 2003, Allergy.

[17]  Y. Shoenfeld,et al.  In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration. , 1999, Journal of autoimmunity.

[18]  M. Dalakas,et al.  Effect of high‐dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: Assessments based on controlled treatment trials in patients with neurological diseases , 1997, Muscle & nerve.

[19]  D. Stroncek,et al.  Neutropenia in a patient receiving intravenous immune globulin , 1996, Journal of Neuroimmunology.

[20]  R. Schiff.  Intravenous gammaglobulin, 2: pharmacology, clinical uses and mechanisms of action , 1994, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[21]  R. Buckley,et al.  The use of intravenous immune globulin in immunodeficiency diseases. , 1991, The New England journal of medicine.

[22]  N. Wilson,et al.  New uses of intravenous immune globulin therapy. , 1991, Western Journal of Medicine.

[23]  Henry Levison,et al.  HIGH-DOSE VERSUS LOW-DOSE INTRAVENOUS IMMUNOGLOBULIN IN HYPOGAMMAGLOBULINAEMIA AND CHRONIC LUNG DISEASE , 1987, The Lancet.

[24]  D. Cournoyer,et al.  Hemolytic anemia following intravenous gamma globulin administration. , 1987, The American journal of medicine.

[25]  H. Friedli.  Methodology and Safety Considerations in the Production of an Intravenous Immunoglobulin Preparation , 1987, Pharmacotherapy.

[26]  B. Pirofsky.  Intravenous immune globulin therapy in hypogammaglobulinemia. A review. , 1984, The American journal of medicine.

[27]  R. Malmberg,et al.  Intravenous γ‐Globulin Infusions in Patients with Hypo‐γ‐Globulinemia 1 , 1978 .

[28]  J. Collier.  FOREIGN BODIES IN THE AIR PASSAGES. , 1889 .

[29]  G. Keskindemirci,et al.  Immediate adverse reactions to intravenous immunoglobulin in children: a single center experience. , 2017, European annals of allergy and clinical immunology.

[30]  N. Pouladi,et al.  Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. , 2009, Journal of investigational allergology & clinical immunology.

[31]  R. Go,et al.  Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. , 2000, Mayo Clinic proceedings.

[32]  R. Malmberg,et al.  Intravenous gamma-globulin infusions in patients with hypo-gamma-globulinemia: prevention of adverse reactions with corticosteroids. , 1978, Vox sanguinis.